Abstract

Saturated-fat intake and endotoxemia can impair cognition. However, their acute impact on cognitive performance is unknown. This study assessed the impact of 2 high-fat meals and endotoxemia on attention. In this double-blind, randomized crossover trial, 51 women (n=32 breast cancer survivors, n=19 noncancer controls; mean ± SD age: 53 ± 8 y) completed the Continuous Performance Test (CPT) and had their blood drawn to assess endotoxemia markers LPS binding protein (LBP), soluble CD14 (sCD14), and the LBP to sCD14 ratio 1 h prior to eating either a high-saturated-fat meal or a high-oleic-sunflower-oil meal. Women again completed the CPT 5 h postmeal. At 1 to 4 wk later, women completed the same protocol but consumed the other meal. In adjusted models, women had more difficulty distinguishing target stimuli from distractors after consuming the high-saturated-fat meal than they did after the oleic-sunflower-oil meal (B=4.44, SE=1.88, P=0.02). Women with higher baseline LBP had less consistent response times (B=0.002, SE=0.0008, P=0.04). Those with higher LBP and LBP:sCD14 were less able to sustain their attention throughout the entire CPT, as reflected by their progressively slower (B=0.002, SE=0.0006, P=0.003; and B=2.43, SE=0.090, P=0.008, respectively) and more erratic (B=0.003, SE=0.0008, P<0.0001; and B=3.29, SE=1.17, P=0.006, respectively) response times. Additionally, women with higher baseline LBP or sCD14 were less able to maintain or increase response speeds at higher interstimulus intervals (B=0.002, SE=0.0006, P=0.02; and B=0.006, SE=0.003, P=0.03, respectively), indicating greater difficulty adapting to changing task demands. Significant meal type by LBP and LBP:sCD14 interactions emerged (P<0.05), such that high LBP and LBP:sCD14 erased between-meal cognitive differences, uniformly impairing performance. These results suggest that higher LBP, sCD14, and LBP:sCD14 and saturated-fat intake individually and jointly influence attention. Endotoxemia may override the relative cognitive benefit of healthier oil choices.This trial is registered at clinicaltrials.gov as NCT04247763.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call